Katherine Stueland, Chief Commercial Officer at Invitae, discusses how genetic testing companies partner with drug developers, including her company’s work with Alnylam.

Invitae is a genetic information company bringing genetic information into mainstream medical practice. Invitae utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process DNA-containing samples, analyze information about patient-specific genetic variation, and generate test reports for clinicians and their patients.